# Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants

> **NCT05493540** · PHASE2 · COMPLETED · sponsor: **Nada Youssef** · enrollment: 80 (actual)

## Conditions studied

- Patent Ductus Arteriosus After Premature Birth
- Patent Ductus Arteriosus Conservative Management

## Interventions

- **DRUG:** Ibuprofen oral suspension
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05493540
- **Lead sponsor:** Nada Youssef
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-15
- **Primary completion:** 2022-08-15
- **Final completion:** 2022-09-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05493540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05493540, "Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05493540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*